Journal of Hepatology
Volume 42, Issue 1 , Pages 132-138, January 2005

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

  • Leon A. Adams

      Affiliations

    • Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
  • ,
  • Schuyler Sanderson

      Affiliations

    • Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
  • ,
  • Keith D. Lindor

      Affiliations

    • Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
  • ,
  • Paul Angulo

      Affiliations

    • Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    • Corresponding Author InformationCorresponding author. Fax: +1 507 266 4531.

Received 19 July 2004; received in revised form 16 September 2004; accepted 21 September 2004. published online 12 October 2004.

See Editorial, pages 12--14

Background/Aims

The histological course of nonalcoholic fatty liver disease (NAFLD) remains undescribed. Therefore, we examined the liver histology of NAFLD patients who had undergone sequential liver biopsies.

Methods

Data on 103 patients who underwent serial liver biopsies in the absence of effective treatment were reviewed, and biopsies scored in a blind fashion.

Results

Mean interval between biopsies was 3.2±3.0 years (range 0.7–21.3). Fibrosis stage apparently progressed in 37%, remained stable in 34% and regressed in 29%. Severity of steatosis, inflammation, hepatocyte ballooning and Mallory's hyaline improved significantly. Aminotransferases decreased significantly between biopsies, paralleling improvement in steatosis and inflammatory features but not fibrosis stage. The rate of fibrosis change ranged from −2.05 to 1.7 stages/year. By multivariate analysis, diabetes (P=0.007) and low initial fibrosis stage (P<0.001) were associated with higher rate of fibrosis progression, as was higher body mass index (P=0.008) when cirrhotics were excluded.

Conclusions

Fibrosis in NAFLD progresses slowly over time with considerable variability in the rate of changes among patients. Changes of aminotransferases do not parallel changes in fibrosis stage. Diabetic patients with elevated BMI and low fibrosis stage are at risk for higher rates of fibrosis progression.

Keywords: Fibrosis, Biopsies, Progression, Cirrhosis, Diabetes, Obesity, Inflammation, Ballooning, Mallory's hyaline

Abbreviations: BMI, body mass index, HDL, high density lipoprotein, NAFLD, nonalcoholic fatty liver disease, NASH, nonalcoholic steatohepatitis, SD, standard deviation

 

 ☆Presented in part during the annual meeting of the American Association for the Study of Liver Diseases, Boston, MA 2003, USA.

PII: S0168-8278(04)00435-0

doi:10.1016/j.jhep.2004.09.012

Journal of Hepatology
Volume 42, Issue 1 , Pages 132-138, January 2005